After losing a child to a rare congenital disorder and a brother to a chronic disease, Dr. Harsha Rajasimha took action. As the founder and CEO of Jeeva, he applied his postdoctoral training at the NIH and FDA, along with his industry experience, to improve access to treatments for rare and chronic diseases. His mission: eliminate clinical trial bottlenecks and accelerate research.
Jeeva partners with sponsors to run modern clinical trials with greater efficiency and lower costs. Its unified platform replaces multiple point solutions and vendors with one secure, streamlined system. With a single login, users gain access to real-time data, monitoring dashboards, and an intuitive digital patient portal.
The platform enhances efficiency for all stakeholders—patients, coordinators, and investigators—by automating repetitive tasks through AI and a patient-first technology stack.
